The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Management of Endocrine Disease: Osteogenesis imperfecta: an update on clinical features and therapies
Open accessAbstract
Osteogenesis imperfecta (OI) is an inherited skeletal dysplasia characterized by bone fragility and skeletal deformities. While the majority of cases are associated with pathogenic variants in COL1A1 and COL1A2, the genes encoding type I collagen, up to 25% of cases are associated with other genes that function within the collagen biosynthesis pathway or are involved in osteoblast differentiation and bone mineralization. Clinically, OI is heterogeneous in features and variable in severity. In addition to the skeletal findings, it can affect multiple systems including dental and craniofacial abnormalities, muscle weakness, hearing loss, respiratory and cardiovascular complications. A multi-disciplinary approach to care is recommended to address not only the fractures, reduced mobility, growth and bone pain but also other extra-skeletal manifestations. While bisphosphonates remain the mainstay of treatment in OI, new strategies are being explored, such as sclerostin inhibitory antibodies and TGF beta inhibition, to address not only the low bone mineral density but also the inherent bone fragility. Studies in animal models have expanded the understanding of pathomechanisms of OI and, along with ongoing clinical trials, will allow to develop better therapeutic approaches for these patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Horwitz, E. M., Gordon, P. L., Koo, W. K. K., Marx, J. C., Neel, M. D., McNall, R. Y., Muul, L., & Hofmann, T. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.132252399 · Cited by 1,650
Marini, J. C., Forlino, A., Bächinger, H. P., Bishop, N. J., Byers, P. H., Paepe, A. D., Fassier, F., Fratzl-Zelman, N., Kozloff, K. M., Krakow, D., et al. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.52 · Cited by 842
One Year of Alendronate after One Year of Parathyroid Hormone (1–84) for Osteoporosis
Black, D. M., Bilezikian, J. P., Ensrud, K. E., Greenspan, S. L., Palermo, L., Hue, T., Lang, T. F., McGowan, J. A., & Rosen, C. J. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050336 · Cited by 614
Nosology and classification of genetic skeletal disorders: 2019 revision
Mortier, G. R., Cohn, D. H., Cormier‐Daire, V., Hall, C., Krakow, D., Mundlos, S., Nishimura, G., Robertson, S., Sangiorgi, L., Savarirayan, R., et al. (2019) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.61366 · Cited by 600
Le Blanc, K., Götherström, C., Ringdén, O., Hassan, M., McMahon, R., Horwitz, E., Anneren, G., Axelsson, O., Nunn, J., Ewald, U., et al. (2005) · Transplantation · doi:10.1097/01.tp.0000159029.48678.93 · Cited by 459
Increased expression of TGF-beta 2 in osteoblasts results in an osteoporosis-like phenotype.
Erlebacher, A., & Derynck, R. (1996) · The Journal of cell biology · doi:10.1083/jcb.132.1.195 · Cited by 371
Excessive transforming growth factor-β signaling is a common mechanism in osteogenesis imperfecta
Grafe, I., Yang, T., Alexander, S., Homan, E. P., Lietman, C., Jiang, M. M., Bertin, T., Munivez, E., Chen, Y., Dawson, B., et al. (2014) · Nature Medicine · doi:10.1038/nm.3544 · Cited by 306
Munns, C. F., Rauch, F., Zeitlin, L., Fassier, F., & Glorieux, F. H. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.040814 · Cited by 276
Semler, O., Garbes, L., Keupp, K., Swan, D., Zimmermann, K., Becker, J., Iden, S., Wirth, B., Eysel, P., Koerber, F., et al. (2012) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2012.06.011 · Cited by 241
Evaluation of teriparatide treatment in adults with osteogenesis imperfecta
Orwoll, E. S., Shapiro, J., Veith, S., Wang, Y., Lapidus, J., Vanek, C., Reeder, J. L., Keaveny, T. M., Lee, D. C., Mullins, M. A., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci71101 · Cited by 210
Götherström, C., Westgren, M., Shaw, S. W. S., Åström, E., Biswas, A., Byers, P. H., Mattar, C. N. Z., Graham, G. E., Taslimi, J., Ewald, U., et al. (2014) · Stem Cells Translational Medicine · doi:10.5966/sctm.2013-0090 · Cited by 206
Spinal Deformity, Pulmonary Compromise, and Quality of Life in Osteogenesis Imperfecta
Widmann, R. F., Bitan, F. D., Laplaza, F. J., Burke, S. W., DiMaio, M. F., & Schneider, R. (1999) · Spine · doi:10.1097/00007632-199908150-00008 · Cited by 206
Causes of death in osteogenesis imperfecta.
McAllion, S. J., & Paterson, C. R. (1996) · Journal of Clinical Pathology · doi:10.1136/jcp.49.8.627 · Cited by 186
Osteocyte-specific WNT1 regulates osteoblast function during bone homeostasis
Joeng, K. S., Lee, Y.-C., Lim, J., Chen, Y., Jiang, M.-M., Munivez, E., Ambrose, C., & Lee, B. H. (2017) · Journal of Clinical Investigation · doi:10.1172/jci92617 · Cited by 180
Osteogenesis imperfecta: advancements in genetics and treatment
Rossi, V., Lee, B., & Marom, R. (2019) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000000813 · Cited by 172
Self-citationBardai, G. K., Moffatt, P., Glorieux, F. H., & Rauch, F. (2016) · Osteoporosis International · doi:10.1007/s00198-016-3709-1 · Cited by 166
Osteogenesis imperfecta – A clinical update
Tournis, S., & Dede, A. D. (2018) · Metabolism · doi:10.1016/j.metabol.2017.06.001 · Cited by 161
Osteogenesis Imperfecta: New Perspectives From Clinical and Translational Research
Tauer, J. T., Robinson, M., & Rauch, F. (2019) · JBMR Plus · doi:10.1002/jbm4.10174 · Cited by 158
Folkestad, L., Hald, J. D., Canudas‐Romo, V., Gram, J., Hermann, A. P., Langdahl, B. L., Abrahamsen, B., & Brixen, K. (2016) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2895 · Cited by 156
Glorieux, F. H., Devogelaer, J., Durigova, M., Goemaere, S., Hemsley, S., Jakob, F. J., JUNKER, U., Ruckle, J., Seefried, L., & Winkle, P. J. (2017) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3143 · Cited by 153
Lindert, U., Cabral, W. A., Ausavarat, S., Tongkobpetch, S., Ludin, K., Barnes, A. M., Yeetong, P., Weis, M., Krabichler, B., Srichomthong, C., et al. (2016) · Nature Communications · doi:10.1038/ncomms11920 · Cited by 146
Otsuru, S., Gordon, P., Shimono, K., Jethva, R., Marino, R., Phillips, C. L., Hofmann, T. J., Veronesi, E., Dominici, M., Iwamoto, M., et al. (2012) · Blood · doi:10.1182/blood-2011-12-400085 · Cited by 144
Osteogenesis imperfecta and therapeutics
Morello, R. (2018) · Matrix Biology · doi:10.1016/j.matbio.2018.03.010 · Cited by 135
Self-citationTwo years’ experience with denosumab for children with Osteogenesis imperfecta type VI
Hoyer‐Kuhn, H., Netzer, C., Koerber, F., Schöenau, E., & Semler, O. (2014) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-014-0145-1 · Cited by 126
Osteogenesis imperfecta: diagnosis and treatment
Palomo, T., Vilaça, T., & Lazaretti‐Castro, M. (2017) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000367 · Cited by 117
Marini, J. C., Hopkins, E., Glorieux, F. H., Chrousos, G. P., Reynolds, J. C., Gundberg, C. M., & Reing, C. M. (2003) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2003.18.2.237 · Cited by 115
Thiele, F., Cohrs, C. M., Flor, A. W., Lisse, T. S., Przemeck, G. K. H., Horsch, M., Schrewe, A., Gailus‐Durner, V., Ivandic, B., Katus, H. A., et al. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds183 · Cited by 84
Otsuru, S., Desbourdes, L. M., Guess, A. J., Hofmann, T. J., Relation, T., Kaito, T., Dominici, M., Iwamoto, M., & Horwitz, E. M. (2017) · Cytotherapy · doi:10.1016/j.jcyt.2017.09.012 · Cited by 77
FAM46A mutations are responsible for autosomal recessive osteogenesis imperfecta
Doyard, M., Bacrot, S., Huber, C., Di Rocco, M., Goldenberg, A., Aglan, M. S., Brunelle, P., Temtamy, S., Michot, C., Otaify, G. A., et al. (2018) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2017-104999 · Cited by 75
Autosomal-Recessive Mutations in MESD Cause Osteogenesis Imperfecta
Moosa, S., Yamamoto, G. L., Garbes, L., Keupp, K., Beleza‐Meireles, A., Moreno, C., Valadares, E. R., de Sousa, S. B., Maia, S., Saraiva, J., et al. (2019) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2019.08.008 · Cited by 73
Pharmacological and biological therapeutic strategies for osteogenesis imperfecta
Marom, R., Lee, Y., Grafe, I., & Lee, B. (2016) · American Journal of Medical Genetics Part C Seminars in Medical Genetics · doi:10.1002/ajmg.c.31532 · Cited by 72
Self-citationSkeletal muscle weakness in osteogeneis imperfecta mice
Gentry, B. A., Ferreira, J. A., McCambridge, A. J., Brown, M., & Phillips, C. L. (2010) · Matrix Biology · doi:10.1016/j.matbio.2010.06.006 · Cited by 67
Bone Healing in Children With Osteogenesis Imperfecta Treated With Bisphosphonates
Pizones, J., Plotkin, H., Parra-Garcia, J. I., Alvarez, P., Gutierrez, P., Bueno, A. I. M., & Fernandez-Arroyo, A. F. (2005) · Journal of Pediatric Orthopaedics · doi:10.1097/01.bpo.0000152940.10487.c9 · Cited by 66
Anthropometry of patients with osteogenesis imperfecta
Lund, A. M., Müller, J., & Skovby, F. (1999) · Archives of Disease in Childhood · doi:10.1136/adc.80.6.524 · Cited by 63
Muscle abnormalities in osteogenesis imperfecta.
Veilleux, L., Trejo, P., & Rauch, F. (2017) · Europe PMC (PubMed Central) · Cited by 62
Generalized Connective Tissue Disease in Crtap-/- Mouse
Baldridge, D., Lennington, J., Weis, M., Homan, E. P., Jiang, M., Munivez, E. M., Keene, D. R., Hogue, W. R., Pyott, S. M., Byers, P. H., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010560 · Cited by 61
Self-citationFiscaletti, M., Biggin, A., Bennetts, B., Wong, K. K. Y., BRIODY, J. N., Pacey, V., Birman, C. S., & Munns, C. F. (2018) · Bone · doi:10.1016/j.bone.2018.01.031 · Cited by 61
Jain, M., Tam, A., Shapiro, J. R., Steiner, R. D., Smith, P. A., Bober, M. B., Hart, T. S., Cuthbertson, D. D., Krischer, J., Mullins, M. A., et al. (2018) · Genetics in Medicine · doi:10.1038/s41436-018-0045-1 · Cited by 55
In utero therapy for congenital disorders using amniotic fluid stem cells
Ramachandra, D. L., Shaw, S. W., Shangaris, P., Loukogeorgakis, S., Guillot, P. V., Coppi, P. D., & David, A. L. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00270 · Cited by 41
The Osteocyte Transcriptome Is Extensively Dysregulated in Mouse Models of Osteogenesis Imperfecta
Zimmerman, S. M., Dimori, M., Heard‐Lipsmeyer, M. E., & Morello, R. (2019) · JBMR Plus · doi:10.1002/jbm4.10171 · Cited by 41
Self-citationBehavioral signs of pain and functional impairment in a mouse model of osteogenesis imperfecta
Abdelaziz, D. M., Abdullah, S., Magnussen, C., Ribeiro‐da‐Silva, A., Komarova, S. V., Rauch, F., & Stone, L. S. (2015) · Bone · doi:10.1016/j.bone.2015.08.001 · Cited by 39
Machol, K., Hadley, T. D., Schmidt, J., Cuthbertson, D. D., Traboulsi, H., da Silva, R. C., Citron, C., Khan, S. I., Citron, K., Carter, E. M., et al. (2019) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.61464 · Cited by 38
Scoliosis and Cardiopulmonary Outcomes in Osteogenesis Imperfecta Patients
Bronheim, R. S., Khan, S. I., Carter, E. M., Sandhaus, R. A., & Raggio, C. (2019) · Spine · doi:10.1097/brs.0000000000003012 · Cited by 37
Craniofacial and Dental Defects in the Col1a1 Jrt/+ Mouse Model of Osteogenesis Imperfecta
Eimar, H. A., Tamimi, F., Retrouvey, J.-M., Rauch, F., Aubin, J. E., & McKee, M. D. (2016) · Journal of Dental Research · doi:10.1177/0022034516637045 · Cited by 36
Sinder, B. P., Novak, S., Wee, N. K. Y., Basile, M., Maye, P. F., Matthews, B. G., & Kalajzić, I. (2019) · Stem Cells · doi:10.1002/stem.3133 · Cited by 35
Osteogenesis Imperfecta: Muscle–Bone Interactions when Bi-directionally Compromised
Phillips, C. L., & Jeong, Y. (2018) · Current Osteoporosis Reports · doi:10.1007/s11914-018-0456-6 · Cited by 33
Gremminger, V. L., Jeong, Y., Cunningham, R. P., Meers, G. M.-E., Rector, R. S., & Phillips, C. L. (2019) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3732 · Cited by 31
Jeong, Y., Carleton, S. M., Gentry, B. A., Yao, X., Ferreira, J. A., Salamango, D. J., Weis, M., Oestreich, A. K., Williams, A. M., McCray, M. G., et al. (2015) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2518 · Cited by 28
Novel mutations in BMP1 induce a rare type of osteogenesis imperfecta
Xu, X., Lv, F., Song, Y., Li, L., Asan, Wei, X., Zhao, X., Jiang, Y., Wang, O., Xing, X., et al. (2018) · Clinica Chimica Acta · doi:10.1016/j.cca.2018.11.004 · Cited by 26
Fracture Healing in Collagen-Related Preclinical Models of Osteogenesis Imperfecta
Zieba, J. T., Munivez, E. M., Castellon, A., Jiang, M., Dawson, B., Ambrose, C. G., & Lee, B. (2020) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3979 · Cited by 26
Respiratory defects in the CrtapKO mouse model of osteogenesis imperfecta
Dimori, M., Heard‐Lipsmeyer, M. E., Byrum, S. D., Mackintosh, S. G., Kurten, R. C., Carroll, J. L., & Morello, R. (2020) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00313.2019 · Cited by 25
Self-citationPokidysheva, E. N., Tufa, S. F., Bresee, C. S., Brigande, J. V., & Bächinger, H. P. (2012) · Matrix Biology · doi:10.1016/j.matbio.2012.11.006 · Cited by 24
Marçal, F. F., Ribeiro, E. M., Costa, F. W. G., Fonteles, C. S. R., Teles, G. S., Silva, P. G. D. B., Chaves, C. M., & Ribeiro, T. R. (2019) · Oral Surgery Oral Medicine Oral Pathology and Oral Radiology · doi:10.1016/j.oooo.2019.07.001 · Cited by 24
Li, L., Zheng, W., Zhao, D., Yu, W., Wang, O., Jiang, Y., Xia, W., & Li, M. (2019) · Bone · doi:10.1016/j.bone.2019.06.011 · Cited by 23
Dental and craniofacial defects in the Crtap−/− mouse model of osteogenesis imperfecta type VII
Xu, H., Lenhart, S. A., Chu, E. Y., Chavez, M. B., Wimer, H. F., Dimori, M., Somerman, M. J., Morello, R., Foster, B. L., & Hatch, N. E. (2020) · Developmental Dynamics · doi:10.1002/dvdy.166 · Cited by 23
Self-citationReznikov, N., Dagdeviren, D., Tamimi, F., Glorieux, F. H., Rauch, F., & Retrouvey, J. (2018) · JBMR Plus · doi:10.1002/jbm4.10124 · Cited by 19
Bone Marrow Transplantation for Treatment of the Col1a2+/G610C Osteogenesis Imperfecta Mouse Model
Lee, L. R., Peacock, L., Ginn, S. L., Cantrill, L. C., Cheng, T. L., Little, D. G., Munns, C. F., & Schindeler, A. (2018) · Calcified Tissue International · doi:10.1007/s00223-018-0504-3 · Cited by 18
The molecular landscape of osteogenesis imperfecta in a Brazilian tertiary service cohort
Fernandes, A. M., Rocha, M. G. M., França, M. M., Lerário, A. M., Simões, V. R. F., Zanardo, É. A., Kulikowski, L. D., Martin, R. M., Mendonca, B. B., & Ferraz‐de‐Souza, B. (2020) · Osteoporosis International · doi:10.1007/s00198-020-05366-4 · Cited by 18
Early Fracture Healing is Delayed in the Col1a2+/G610C Osteogenesis Imperfecta Murine Model
Besio, R., Maruelli, S., Battaglia, S., Leoni, L., Villani, S., Layrolle, P., Rossi, A., Trichet, V., & Forlino, A. (2018) · Calcified Tissue International · doi:10.1007/s00223-018-0461-x · Cited by 14
Cited by
Sclerostin inhibition in rare bone diseases: Molecular understanding and therapeutic perspectives
Xiaohui, T., Wang, L., Yang, X., Jiang, H., Zhang, N., Zhang, H., Li, D., Li, X., Zhang, Y., Wang, S., et al. (2024) · Journal of Orthopaedic Translation · doi:10.1016/j.jot.2024.05.004 · Cited by 10
“Rare bone diseases, including osteogenesis imperfecta (OI) and X-linked hypophosphatemia (XLH), affect the musculoskeletal system and may cause severe mobility problems due to painful fractures, de-formities, and bone pain [5,6].”
Background
Metadata
- Authors
- Marom, R., Rabenhorst, B. M., & Morello, R.
- Venue
- European Journal of Endocrinology
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-10
- Volume
- 183
- Issue
- 4
- Pages
- R95-R106
- ISSN
- 0804-4643 (ISSN-L)
- 1479-683X
- OpenAlex
- W3039181784
- Cited by
- 263
- References
- 59
- FWCI
- 14.52
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.